Manhattan Scientifics, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019
August 19, 2019 at 09:06 pm
Share
Manhattan Scientifics, Inc. announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced sales was USD 50,000 compared to USD 0 a year ago. Operating loss was USD 490,000 compared to USD 1.239 million a year ago. Net loss was USD 908,000 compared to USD 2.213 million a year ago. For the half year, sales was USD 50,000 compared to USD 0 a year ago. Operating loss was USD 711,000 compared to USD 1.668 million a year ago. Net loss was USD 1.344 million compared to USD 5.041 million a year ago. Basic eps - continuing operations was USD 0 compared to basic loss per share from continuing operations of USD 0.01 a year ago.
Manhattan Scientifics, Inc. is focused on technology transfer and commercialization of these transformative technologies. The Company operates as a technology incubator. Its business model is to identify significant technologies; acquire them or the rights to them; secure the services of inventors, engineers or other staff who were instrumental in their creation; provide or contract for suitable work facilities, laboratories, and other aids where appropriate; prototype the technologies to demonstrate proof of principle feasibility; secure patent and or other intellectual property protection; secure early customers for product trials where feasible and appropriate; and commercialize through licenses, sales or cooperative efforts with other manufacturing and distribution firms. Its business model is based on licensing metals technology to metals manufacturers. Its technologies are in a development phase.
MANHATTAN SCIENTIFICS, INC. 
